Fig. 3
In silico analysis of TMED9 expression in hepatocellular carcinoma (HCC). a, b Relative TMED9 mRNA levels (208757_at) in 30 pre-neoplastic lesions (including 13 cirrhotic samples and 17 dysplastic samples) and 35 HCC (including 18 early-stage and 17 advanced-stage HCC) samples from GSE6764 microarray datasets. Expression data were normalized to the median intensity of all probes and scaled to log2 transformation. c Expression levels of TMED9 transcripts in normal and HCC samples. d Kaplan–Meier curves for overall survival of patients with HCC, as categorized according to high or low expression of TMED9. The p value indicates a comparison between patients with TMED9high and TMED9low. Data in both c and d are from GEPIA online available databases (http://gepia.cancer-pku.cn/index.html)